Corza Medical Completes Acquisition of TachoSil Manufacturing Operations
01 juil. 2024 07h57 HE
|
Corza Medical Inc.
Corza Medical successfully closed its previously announced acquisition of the TachoSil manufacturing operations in Linz, Austria.
Corza Medical Named “Best Overall MedTech Company” in 8th Annual MedTech Breakthrough Awards Program
09 mai 2024 10h30 HE
|
Corza Medical Inc.
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies WESTWOOD, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Corza Medical...
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
30 nov. 2023 08h05 HE
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
Corza Medical & Envision announce strategic partnership
28 sept. 2023 08h05 HE
|
Corza Medical Inc.
Corza Medical and Envision announce today that they have entered into a strategic partnership to propel ophthalmic health forward
Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
26 avr. 2023 09h03 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...
Corza Medical Announces Direct Distribution of TachoSil® to the US Market
20 avr. 2023 09h05 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...